Bellicum Pharmaceuticals Inc | TalkMarkets

Latest Posts

US Stock Market Weekly Review Nov. 2 - 6, 2020

Article By: Stavros Georgiadis

Sunday, November 8, 2020 6:33 PM EDT

The stock market hates uncertainty, but the prolonged time to announce a clear winner for this presidential election was ignored by the investors.

In this article: FTCH, BLCM, UPWK, EQ, KBLM

Read

Morning Call For Tuesday, April 17

Article By: Jim Van Meerten

Tuesday, April 17, 2018 9:32 AM EDT

Jun E-mini S&Ps (ESM18 +0.46%) this morning are up +0.47% at a 3-week high on expectations of strong S&P 500 Q1 corporate earnings results.

In this article: CE, DG, MRK, PAG, PGR, SEAC, NFLX, GRUB, BLCM, ACIA, CRSP, ROKU, VIVE

Read

Juno, CAR-T Peers Rise After Report Of Potential Celgene Deal

Article By: The Fly

Wednesday, January 17, 2018 12:59 PM EDT

Shares of Juno Therapeutics are on the rise after the Wall Street Journal reported that the company is in talks to be acquired by Celgene.

In this article: JUNO Also: CELG, GILD, BLUE, CLLS, BLCM

Read

CytomX Long Term Returns Uncertain

Article By: Don Dion

Tuesday, October 6, 2015 12:00 PM EDT

CTMX is the largest biotech this week to debut; investors could buy in at higher rates than slightly lower profile firms. CTMX has impressive partnerships with big pharma and is backed by Third Rock Ventures, Fidelity and Pfizer.

In this article: AZN, GSK, MRK, NVS, PFE, ROG, SNY, VRX, IDRA, IMGN, NLNK, SGEN, CELG, JUNO, KITE, BLUE, BLCM, ACRS

Read

CAR T-Cell Therapeutics: Alan Leong Of BioWatch Looks Beyond The Buzz For Solid Early-Stage Plays

Article By: The Life Sciences Report

Wednesday, September 9, 2015 5:45 PM EDT

Alan Leong, senior analyst with BioWatch, tells us about the latest in CAR T-cell therapeutics and how some companies are hedging their bets by developing bispecific antibodies.